Listed

Thermo Fisher Scientific Inc.: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Feb 25, 2021 and accepted by EDGAR at Feb 24, 2021, 17:36 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$32.22bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development12 months2020-01-01 to 2020-12-31$1.18bnus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2020-01-01 to 2020-12-31$6.93bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2020-01-01 to 2020-12-31$7.79bnus-gaap:OperatingIncomeLoss
Interest expense12 months2020-01-01 to 2020-12-31$553.0mus-gaap:InterestExpense
Income tax12 months2020-01-01 to 2020-12-31$850.0mus-gaap:IncomeTaxExpenseBenefit
Diluted EPS12 months2020-01-01 to 2020-12-31$15.96us-gaap:EarningsPerShareDiluted
Basic EPS12 months2020-01-01 to 2020-12-31$16.09us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2020-01-01 to 2020-12-31399,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2020-01-01 to 2020-12-31$8.29bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$1.47bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2020-01-01 to 2020-12-31$337.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases12 months2020-01-01 to 2020-12-31$1.50bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$10.32bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$21.96bnus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$69.05bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$10.30bnus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-12-31$19.11bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-12-31$2.63bnus-gaap:DebtCurrent
Shareholders' equityAt period end2020-12-31$34.51bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000097745-21-000011. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.